Express Pharma - Page 20 of 2164 - Express Pharma

The invisible threat: Why packaging inks are the next major recall risk for pharma

Advanced excipients: India’s gate to high-value drug formulation

Rx Propellant appoints Ashish Singh as CEO and MD

Lupin receives tentative U.S. FDA approval for Siponimod Tablets

Medley launches Biscal D –Calcium and Vitamin D3 fortified biscuit

Lupin signs exclusive licensing agreement with Valorum Biologics for Armlupeg in the U.S.

Granules India reports completion of FDA inspection with zero observations

Urgent reforms to ensure safe medicines: Need of the hour

India pharma and healthcare funding reaches $38.6 million in November 2025

Corona Remedies announces IPO opening on 8 December 2025

Cipla launches Ciplostem cell therapy for Knee Osteoarthritis in India

Merck announces winners of the Merck Young Scientist Award 2025

Green Pharma: How the industry can reduce its carbon footprint without compromising growth